Cited 16 times in 
Cited 13 times in 
Hypertension and Heart Failure with Preserved Ejection Fraction
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee , Chan Joo | - |
| dc.contributor.author | Park, Sung Ha | - |
| dc.date.accessioned | 2021-09-29T01:28:55Z | - |
| dc.date.available | 2021-09-29T01:28:55Z | - |
| dc.date.created | 2022-04-12 | - |
| dc.date.issued | 2021-07 | - |
| dc.identifier.issn | 1551-7136 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/184384 | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | Elsevier/Saunders | - |
| dc.relation.isPartOf | Heart Failure Clinics | - |
| dc.relation.isPartOf | HEART FAILURE CLINICS | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Hypertension and Heart Failure with Preserved Ejection Fraction | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Lee , Chan Joo | - |
| dc.contributor.googleauthor | Park, Sung Ha | - |
| dc.identifier.doi | 10.1016/j.hfc.2021.02.002 | - |
| dc.relation.journalcode | J02912 | - |
| dc.subject.keyword | Antihypertensive agents | - |
| dc.subject.keyword | Blood pressure | - |
| dc.subject.keyword | Hypertension | - |
| dc.subject.keyword | Heart failure | - |
| dc.contributor.alternativeName | Park, Sung Ha | - |
| dc.contributor.affiliatedAuthor | Lee , Chan Joo | - |
| dc.contributor.affiliatedAuthor | Park, Sung Ha | - |
| dc.identifier.scopusid | 2-s2.0-85106496720 | - |
| dc.identifier.wosid | 000654985000004 | - |
| dc.citation.volume | 17 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 337 | - |
| dc.citation.endPage | 343 | - |
| dc.identifier.bibliographicCitation | Heart Failure Clinics, Vol.17(3) : 337-343, 2021-07 | - |
| dc.identifier.rimsid | 73261 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Antihypertensive agents | - |
| dc.subject.keywordAuthor | Blood pressure | - |
| dc.subject.keywordAuthor | Hypertension | - |
| dc.subject.keywordAuthor | Heart failure | - |
| dc.subject.keywordPlus | BLOOD-PRESSURE | - |
| dc.subject.keywordPlus | SPIRONOLACTONE | - |
| dc.subject.keywordPlus | OUTCOMES | - |
| dc.subject.keywordPlus | PATHOPHYSIOLOGY | - |
| dc.subject.keywordPlus | EPIDEMIOLOGY | - |
| dc.subject.keywordPlus | IRBESARTAN | - |
| dc.subject.keywordPlus | DIAGNOSIS | - |
| dc.subject.keywordPlus | BLOCKERS | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
| dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.